{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:26:03Z","timestamp":1790375163392,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ahj.2017.08.023","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T22:01:09Z","timestamp":1504303269000},"page":"116-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non\u2013infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Disease"],"prefix":"10.1016","volume":"194","author":[{"given":"Sameer A.","family":"Hirji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna R.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda K.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Michael H.","family":"Sketch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Matthew","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2017.08.023_bb0005","first-page":"e362","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.023_bb0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ahj.2004.03.051","article-title":"Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction","volume":"148","author":"Corpus","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.08.023_bb0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.amjcard.2010.03.029","article-title":"Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry)","volume":"106","author":"Dziewierz","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2017.08.023_bb0020","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/hrt.2010.197673","article-title":"Prevalence and impact of a chronic total occlusion in a non\u2013infarct-related artery on long-term mortality in diabetic patients with ST elevation myocardial infarction","volume":"96","author":"Claessen","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2017.08.023_bb0025","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2014.15095","article-title":"Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction","volume":"312","author":"Park","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2017.08.023_bb0030","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","article-title":"Randomized trial of preventive angioplasty in myocardial infarction","volume":"369","author":"Wald","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.08.023_bb0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial","volume":"386","author":"Engstr\u00f8m","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.08.023_bb0040","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.athoracsur.2006.04.044","article-title":"Selection of surgical or percutaneous coronary intervention provides differential longevity benefit","volume":"82","author":"Smith","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2017.08.023_bb0045","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/01.CIR.89.5.2015","article-title":"Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty","volume":"89","author":"Mark","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.023_bb0050","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0735-1097(03)01050-7","article-title":"Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial","volume":"42","author":"Webb","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.08.023_bb0055","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/hrt.2009.177162","article-title":"A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up","volume":"96","author":"Politi","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2017.08.023_bb0060","series-title":"Analysing survival data from clinical trials and observational studies","author":"Marubini","year":"1995"},{"key":"10.1016\/j.ahj.2017.08.023_bb0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2017.08.023_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjcard.2009.04.016","article-title":"Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)","volume":"104","author":"Cavender","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2017.08.023_bb0075","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jacc.2009.11.061","article-title":"The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial: can we deliver on its promise?","volume":"55","author":"O'Gara","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.08.023_bb0080","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ahj.2013.07.027","article-title":"Non\u2013infarct-related artery revascularization during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis","volume":"166","author":"Bagai","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.08.023_bb0085","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.jacc.2015.09.099","article-title":"Complete versus lesion-only primary PCI: the randomized cardiovascular MR CvLPRIT substudy","volume":"66","author":"McCann","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.08.023_bb0090","first-page":"282","article-title":"Preventive angioplasty in myocardial infarction","volume":"370","author":"White","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.08.023_bb0095","doi-asserted-by":"crossref","first-page":"23A","DOI":"10.1016\/j.amjcard.2015.01.004","article-title":"Updates to the ACCF\/AHA and ESC STEMI and NSTEMI guidelines: putting guidelines into clinical practice","volume":"115","author":"Wessler","year":"2015","journal-title":"Am J Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031730265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031730265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:59:33Z","timestamp":1757570373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287031730265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":19,"alternative-id":["S000287031730265X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.08.023","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non\u2013infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}